Chern Ein Oon

3.7k citations

71 papers · 2.8k indexed · 2 hit papers · h-index 23

Impact in

Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
Molecular Biology top 5%
- Extracellular vesicles in disease
- Circular RNAs in diseases
- Angiogenesis and VEGF in Cancer
- RNA Interference and Gene Delivery

Papers in ⓘ

Applied Microbiology and Biotechnology 5
- Tannin, Tannase and Anticancer Activities 5
Geriatrics and Gerontology 7
- Sirtuins and Resveratrol in Medicine 7

Co-authors: Yi Jer Tan (9 shared papers)Yeuan Ting Lee (9 shared papers)Adrian L. Harris (6 shared papers)Gurjeet Kaur (9 shared papers)Amin Malik Shah Abdul Majid (21 shared papers)Venugopal Balakrishnan (7 shared papers)Richard C.A. Sainson (5 shared papers)Russell Leek (4 shared papers)
Journals: Life Sciences (4 papers)European Journal of Pharmacology (3 papers)Biomedicine & Pharmacotherapy (3 papers)Journal of Ethnopharmacology (2 papers)Drug and Chemical Toxicology (2 papers)
Partner nations: Malaysia Australia United Kingdom

In The Last Decade

Chern Ein Oon

69 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine 2022 · 155 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Acta Pharmaceutica Sinica B
2018 European Journal of Pharmacology

Peers

Countries citing papers authored by Chern Ein Oon

Since Specialization

Citations

This map shows the geographic impact of Chern Ein Oon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chern Ein Oon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chern Ein Oon more than expected).

Fields of papers citing papers by Chern Ein Oon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chern Ein Oon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chern Ein Oon. The network helps show where Chern Ein Oon may publish in the future.

Co-authors

The 25 scholars most cited alongside Chern Ein Oon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chern Ein Oon Line = papers co-authored together Chern Ein Oon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Molecular targeted therapy: Treating cancer with specificity European Journal of Pharmacology ·Yeuan Ting Lee, Yi Jer Tan, Chern Ein Oon Hit paper breakdown →	2018	767
2	New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes Blood ·Helen Sheldon, Emily Heikamp, Helen Turley, Rebecca Dragovic, Peter H. Thomas, Chern Ein Oon, Russell Leek, Mariola J. Edelmann, Benedikt M. Kessler, Richard C.A. Sainson, Ian L. Sargent, Jiliang Li, Adrian L. Harris	2010	328
3	DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In Vivo Cancer Research ·Jiliang Li, Richard C.A. Sainson, Chern Ein Oon, Helen Turley, Russell Leek, Helen Sheldon, Esther Bridges, Wen Shi, Cameron Snell, Emma T. Bowden, Herren Wu, Partha S. Chowdhury, Angela J. Russell, Craig P. Montgomery, Richard Poulsom, Adrian L. Harris	2011	187
4	Key Molecular Events in Cervical Cancer Development Medicina ·Shandra Devi Balasubramaniam, Venugopal Balakrishnan, Chern Ein Oon, Gurjeet Kaur	2019	170
5	Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine Acta Pharmaceutica Sinica B ·Yeuan Ting Lee, Yi Jer Tan, Chern Ein Oon Hit paper breakdown →	2022	155
6	Evaluation of the cytotoxicity, cell-cycle arrest, and apoptotic induction byEuphorbia hirtain MCF-7 breast cancer cells Pharmaceutical Biology ·Yuet Ping Kwan, Tamio Saito, Darah Ibrahim, Faisal Muti Al-Hassan, Chern Ein Oon, Yeng Chen, Subramanion L. Jothy, Jagat R. Kanwar, Sreenivasan Sasidharan	2015	84
7	Anticancer attributes of Illicium verum essential oils against colon cancer South African Journal of Botany ·Muhammad Asif, Ashwaq Hamid Salem Yehya, Majed Ahmed Al‐Mansoub, Vageesh Revadigar, Mohammed Oday Ezzat, Mohamed B. Khadeer Ahamed, Chern Ein Oon, Vikneswaran Murugaiyah, Aman Shah Abdul Majid, Amin Malik Shah Abdul Majid, (unknown), (unknown)	2015	67
8	Angiogenesis: Managing the Culprits behind Tumorigenesis and Metastasis Medicina ·Ashwaq Hamid Salem Yehya, Muhammad Asif, Sven Petersen, Ayappa V. Subramaniam, Koji Kono, Amin Malik Shah Abdul Majid, Chern Ein Oon	2018	62
9	Human colon cancer targeted pro-apoptotic, anti-metastatic and cytostatic effects of binuclear Silver(I)– N -Heterocyclic carbene (NHC) complexes European Journal of Medicinal Chemistry ·Muhammad Asif, Muhammad Adnan Iqbal, Mouayed A. Hussein, Chern Ein Oon, Rosenani A. Haque, Mohamed B. Khadeer Ahamed, Aman Shah Abdul Majid, Amin Malik Shah Abdul Majid, (unknown), (unknown)	2015	60
10	Scopoletin, an active principle of tree tobacco (Nicotiana glauca) inhibits human tumor vascularization in xenograft models and modulates ERK1, VEGF-A, and FGF-2 in computer model Microvascular Research ·Yasser Tabana, Loiy Elsir Ahmed Hassan, Mohamed B. Khadeer Ahamed, Saad Sabbar Dahham, Muhammad Adnan Iqbal, Mohammed Ali Ahmed Saeed, Md Shamsuddin Sultan Khan, Doblin Sandai, Amin Malik Shah Abdul Majid, Chern Ein Oon	2016	53
11	Notch Regulation of Tumor Angiogenesis Future Oncology ·Esther Bridges, Chern Ein Oon, Adrian L. Harris	2011	49
12	Lactobacillus Strains Alleviated Aging Symptoms and Aging-Induced Metabolic Disorders in Aged Rats Journal of Medicinal Food ·Yan-Yan Hor, Cheong Hwa Ooi, Boon Yin Khoo, Sy Bing Choi, Azman Seeni, Shaharum Shamsuddin, Chern Ein Oon, Kee-Leong Ong, Woo‐Sik Jeong, Min‐Tze Liong	2018	42
13	A titanium dioxide/nitrogen-doped graphene quantum dot nanocomposite to mitigate cytotoxicity: synthesis, characterisation, and cell viability evaluation RSC Advances ·Pravena Ramachandran, Chong Yew Lee, Ruey‐an Doong, Chern Ein Oon, Nguyễn Thị Kim Thanh, Hooi Ling Lee	2020	41
14	SIRT1 inhibition in pancreatic cancer models: Contrasting effects in vitro and in vivo European Journal of Pharmacology ·Chern Ein Oon, Carina Strell, Keng Yoon Yeong, Arne Östman, Jai Prakash	2015	38
15	Isoledene from Mesua ferrea oleo-gum resin induces apoptosis in HCT 116 cells through ROS-mediated modulation of multiple proteins in the apoptotic pathways: A mechanistic study Toxicology Letters ·Muhammad Asif, Armaghan Shafaei, Seyedeh Fatemeh Jafari, Shazmin Kithur Mohamed, Mohammed Oday Ezzat, Aman Shah Abdul Majid, (unknown), Chern Ein Oon, Sven Petersen, Koji Kono, Amin Malik Shah Abdul Majid	2016	38
16	MicroRNAs: Biogenesis, Roles for Carcinogenesis and as Potential Biomarkers for Cancer Diagnosis and Prognosis Asian Pacific Journal of Cancer Prevention ·Nowroji Kavitha, Soundararajan Vijayarathna, Subramanion L. Jothy, Chern Ein Oon, Yeng Chen, Jagat R. Kanwar, Sreenivasan Sasidharan	2014	38
17	Role of Delta-like 4 in Jagged1-induced tumour angiogenesis and tumour growth Oncotarget ·Chern Ein Oon, Esther Bridges, Helen Sheldon, Richard C.A. Sainson, Adrian M. Jubb, Helen Turley, Russell Leek, Francesca M. Buffa, Adrian L. Harris, Jiliang Li	2017	34
18	Minichromosome Maintenance Complex (MCM) Genes Profiling and MCM2 Protein Expression in Cervical Cancer Development Asian Pacific Journal of Cancer Prevention ·Gurjeet Kaur, Shandra Devi Balasubramaniam, Yung Jen Lee, Venugopal Balakrishnan, Chern Ein Oon	2019	34
19	Cancer-Associated Fibroblasts: Epigenetic Regulation and Therapeutic Intervention in Breast Cancer Cancers ·Yeuan Ting Lee, Yi Jer Tan, Marco Falasca, Chern Ein Oon	2020	34
20	Anticancer Activities of a Benzimidazole Compound Through Sirtuin Inhibition in Colorectal Cancer Future Medicinal Chemistry ·Yi Jer Tan, Yeuan Ting Lee, Keng Yoon Yeong, Sven Petersen, Koji Kono, Soo Choon Tan, Chern Ein Oon	2018	33

About Chern Ein Oon

Chern Ein Oon is a scholar working on Applied Microbiology and Biotechnology, Geriatrics and Gerontology, Cancer Research, Molecular Biology and Biochemistry, having authored 71 papers that have together received 2.8k indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (7 papers), Histone Deacetylase Inhibitors Research (7 papers), Phytochemical compounds biological activities (7 papers), Bioactive Compounds in Plants (7 papers), Angiogenesis and VEGF in Cancer (7 papers), Gut microbiota and health (6 papers), Cervical Cancer and HPV Research (6 papers) and Tannin, Tannase and Anticancer Activities (5 papers). The work is most often cited by research in Cancer Research (682 citations), Molecular Biology (1.6k citations), Geriatrics and Gerontology (81 citations), Oncology (533 citations) and Toxicology (58 citations). Chern Ein Oon has collaborated with scholars based in Malaysia, Australia and United Kingdom. Frequent co-authors include Yi Jer Tan, Yeuan Ting Lee, Adrian L. Harris, Gurjeet Kaur, Amin Malik Shah Abdul Majid, Venugopal Balakrishnan, Richard C.A. Sainson, Russell Leek, Jiliang Li and Helen Sheldon. Their work appears in journals such as Life Sciences, European Journal of Pharmacology, Biomedicine & Pharmacotherapy, Journal of Ethnopharmacology and Drug and Chemical Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact